flufirvitide
Peptideexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2011 (NCT01313962)
Timeline
Indications
Studied for
Mechanism of action
- HemagglutininINHIBITOR
HA inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- flufirvitide
- flufirvitide-3
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02423577 | Phase 2 | Sep 1, 2015 | Autoimmune Technologies, LLC, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01990846 | Phase 1 | Mar 1, 2014 | Autoimmune Technologies, LLC |
| NCT01313962 | Phase 1 | Aug 1, 2011 | Autoimmune Technologies, LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Autoimmune Technologies, LLC | For profit | 3 | 3 | 2 | 2011 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1